lead plaintiff

Class action lawsuit filed against Alight alleging executives made false statements on CEO transition, capital returns, and revenue targets. Investors have until May 15, 2026 to join.

Apollo Global Management faces class action lawsuit for concealing executive communications with Jeffrey Epstein. Stock fell 16% during alleged fraud period.

NuScale Power ($SMR) faces securities fraud class action for allegedly misrepresenting ENTRA1 Energy's qualifications. Stock plunged 14.4% after $495M payment disclosure.

Pomerantz LLP filed class action against $IT for alleged securities fraud tied to two major stock declines. Investors have until May 18, 2026, to join the lawsuit.

PayPal shareholders targeted in class action alleging misstatements on Branded Checkout initiatives. Stock fell 20.3% following CEO replacement and disappointing earnings.

Law firm Kirby McInerney reminds Eos Energy investors of May 5, 2026 deadline to join securities lawsuit alleging missed guidance and disclosure failures.

Pinterest faces class action lawsuit alleging misleading statements about advertising revenue amid tariff-related deterioration. Stock dropped $12.77 per share.

Robbins Geller files class action against $MEDP over alleged false book-to-bill projections. Stock fell 16% after Q4 miss. Lead plaintiff deadline: June 8, 2026.

ImmunityBio faces securities fraud lawsuit after FDA warning over false Anktiva claims. Stock plunged 21%. Investor deadline May 26, 2026.

Law firm files class action lawsuit against Pinterest for allegedly making false statements about advertising revenues and tariff impacts. Stock dropped 16.8% after disappointing earnings.

Lufax ($LU) faces class action lawsuit alleging securities fraud, financial misstatement, and inadequate internal controls spanning April 2023 to January 2025. Lead plaintiff deadline set for May 20, 2026.

Rosen Law Firm launches securities class action against Trip.com ($TCOM) over alleged false regulatory risk disclosures. Lead plaintiff deadline: May 11, 2026.

Rosen Law Firm launches securities class action against Apollo Global Management ($APO) alleging false statements about Epstein business dealings. May 1, 2026 deadline for lead plaintiff applications.

$LU shareholders can lead securities fraud lawsuit alleging Lufax failed to disclose internal control weaknesses and misstated financials between April 2023-January 2025.

Class action filed against $SLNO for allegedly failing to disclose safety concerns about DCCR drug. Stock fell sharply after August 2025 short report and September patient death disclosure.

Kahn Swick & Foti sues Navan for allegedly concealing 39% spike in sales/marketing expenses to $95M in Q3 2025 during October IPO. Deadline April 24, 2026.

ImmunityBio hit with securities fraud class action following FDA warning letter over misleading Anktiva cancer therapy ads. Stock fell 21% to $7.42.

Three companies face securities class action suits alleging material misstatements. Investors must apply by May 18, 2026 for $GEMINI; earlier deadlines for $SLNO and $NAVAN.

Law firm files class action against $ENPH for allegedly overstating inventory management and financial prospects during 2025.

Class action lawsuit filed against $ATRA over alleged misstatements on tabelecleucel prospects. FDA rejected drug twice; stock crashed 40-57% post-announcements.